Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Adv Exp Med Biol. 2012;727:174-85. doi: 10.1007/978-1-4614-0899-4_13.
Subpopulations of cancer cells with stem cell-like characteristics, termed cancer stem cells, have been identified in a wide range of human cancers. Cancer stem cells are defined by their ability to self-renew as well as recapitulate the original heterogeneity of cancer cells in culture and in serial xenotransplants. Not only are cancer stem cells highly tumorigenic, but these cells are implicated in tumor resistance to conventional chemotherapy and radiotherapy, thus highlighting their significance as therapeutic targets. Considerable similarities have been found between cancer stem cells and normal stem cells on their dependence on certain signaling pathways. More specifically, the core stem cell signaling pathways, such as the Wnt, Notch and Hedgehog pathways, also critically regulate the self-renewal and survival of cancer stem cells. While the oncogenic functions of Notch pathway have been well documented, its role in cancer stem cells is just emerging. In this chapter, we will discuss recent advances in cancer stem cell research and highlight the therapeutic potential of targeting Notch in cancer stem cells.
在多种人类癌症中,已经鉴定出具有干细胞样特征的癌细胞亚群,称为癌症干细胞。癌症干细胞的定义是它们能够自我更新,并且能够在培养物和连续异种移植中再现癌细胞的原始异质性。癌症干细胞不仅具有高度致瘤性,而且这些细胞与肿瘤对常规化疗和放疗的耐药性有关,因此强调了它们作为治疗靶点的重要性。在对某些信号通路的依赖性方面,癌症干细胞与正常干细胞之间存在相当多的相似之处。更具体地说,核心干细胞信号通路,如 Wnt、Notch 和 Hedgehog 通路,也严格调节癌症干细胞的自我更新和存活。虽然 Notch 通路的致癌功能已得到充分证实,但它在癌症干细胞中的作用才刚刚出现。在本章中,我们将讨论癌症干细胞研究的最新进展,并强调针对癌症干细胞中的 Notch 进行靶向治疗的潜在治疗效果。